Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.UK-based FDS Pharma has purchased the SciGen Israel's Rehovot hepatitis vaccine manufacturing plant for $2m in addition to 5% royalties on sales.
Subscribe to our email newsletter
Run by Russian executives, FDS Pharma owns patents to vaccines and produces active pharmaceutical ingredients (APIs) for the Russian and other markets, according to globes.co.il.
Singapore-based SciGen, a subsidiary of Bioton is a fully integrated biotechnology company developing, manufacturing, and marketing biopharmaceuticals.
SciGen has set up the SciGen Israel plant for $10m, because of the financial difficulties, SciGen has divested SciGen Israel and its vaccine production and marketing rights.